Shilpa Medicare informs about disclosure

15 Mar 2025 Evaluate
Shilpa Medicare has informed that United States Food and Drugs Administration (USFDA) has conducted an inspection at Unit-2 of Shilpa Pharma Lifesciences, located at Raichur from March 10-14, 2025. The inspection was closed with ZERO observations. This is second consecutive ZERO 483 inspection from USFDA at this site.

The above information is a part of company’s filings submitted to BSE.



Shilpa Medicare Share Price

266.40 -4.25 (-1.57%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×